Cesca Therapeutics Inc. (KOOL) financial statements (2021 and earlier)

Company profile

Business Address 2711 CITRUS ROAD
RANCHO CORDOVA, CA 95742
State of Incorp. DE
Fiscal Year End December 31
SIC 3821 - Laboratory Apparatus and Furniture (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments73246315
Cash and cash equivalents73246315
Receivables1124355
Inventory, net of allowances, customer advances and progress billings6444456
Inventory6444456
Other undisclosed current assets1200000
Total current assets:1510911131325
Noncurrent Assets
Inventory, Noncurrent1      
Operating lease, right-of-use asset11
Property, plant and equipment1232332
Intangible assets, net (including goodwill)22233343435
Goodwill11113131313
Intangible assets, net (excluding goodwill)11220212122
Restricted cash and investments  1    
Other noncurrent assets0000000
Total noncurrent assets:65636373838
TOTAL ASSETS:21151547505163
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2232364
Accounts payable1122354
Employee-related liabilities0010011
Deferred revenue11
Debt0      
Due to related parties   1   
Deferred revenue and credits1111
Contract with customer, liability0
Other liabilities1211222
Other undisclosed current liabilities222    
Total current liabilities:6765686
Noncurrent Liabilities
Long-term debt and lease obligation12  2  
Long-term debt, excluding current maturities01  2  
Operating lease, liability11
Liabilities, other than long-term debt852121088
Deferred revenue22
Deferred tax liabilities, net 7888
Due to related parties6414   
Other liabilities0000100
Derivative instruments and hedges, liabilities  011  
Other undisclosed noncurrent liabilities00     
Total noncurrent liabilities:982121288
Total liabilities:1514816181614
Stockholders' equity
Stockholders' equity attributable to parent60831323549
Common stock0000000
Additional paid in capital259237236216189173171
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)0
Accumulated deficit(253)(237)(227)(185)(156)(138)(123)
Stockholders' equity attributable to noncontrolling interest01(2)    
Total stockholders' equity:61731323549
TOTAL LIABILITIES AND EQUITY:21151547505163

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues10131015121616
Revenue, net15121616
Cost of revenue(8)(7)(7)(9)(9)(11)(10)
Cost of goods and services sold(8)(7)(7)    
Other undisclosed gross profit     (0) 
Gross profit:1626356
Operating expenses(10)(10)(46)(15)(14)(20)(15)
Operating loss:(9)(5)(44)(9)(11)(15)(9)
Nonoperating income (expense)0(0)(0)(21)(8) 0
Other nonoperating income (expense)0(0)(0)0(0)  
Interest and debt expense(8)(5)(3)(11)(1)  
Loss from continuing operations before equity method investments, income taxes:(17)(10)(46)(40)(19)(15)(9)
Loss from equity method investments(0)(0)     
Other undisclosed income from continuing operations before income taxes 0111 0 
Loss from continuing operations before income taxes:(17)(10)(46)(30)(19)(15)(9)
Income tax benefit  51  0
Net loss:(17)(10)(41)(29)(19)(15)(9)
Net income attributable to noncontrolling interest011    
Other undisclosed net income attributable to parent    1  
Net loss available to common stockholders, diluted:(16)(9)(40)(29)(19)(15)(9)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss:(17)(10)(41)(29)(19)(15)(9)
Other undisclosed comprehensive income000    
Comprehensive loss:(17)(10)(41)(29)(19)(15)(9)
Comprehensive income, net of tax, attributable to noncontrolling interest011    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (0)1(0)0
Comprehensive loss, net of tax, attributable to parent:(16)(9)(40)(29)(19)(15)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: